Avid Bioservices, Inc. (CDMO)
CDMO Price and Sentiment
CDMO Latest news
Avid Bioservices Appoints Elie G. Hanania, Ph.D.
2021-11-04 08:05Seasoned Life Science Industry Executive with More Than 30 Years of Experience in Cell and Gene Therapy, Including Senior Level Viral Vector Development Positions with Fujifilm Diosynth Biotechnologies and Millipore Sigma Seasoned Life Science Industry Executive with More Than 30 Years of Experience in Cell and Gene Therapy, Including Senior Level Viral Vector Development Positions with Fujifilm Diosynth Biotechnologies and Millipore Sigma
Will The Rally In Avid Bioservices Stock Continue After 48% Rise In A Month?
2021-11-01 07:00The stock price of Avid Bioservices, a contract development and manufacturing company for biopharmaceutical products, has surged 48% in a month (twenty-one trading days), while it is up a solid 19% in a week. The recent rise can be attributed to CDMO's inclusion in the S&P SmallCap 600 index.
Why Avid Bioservices Stock Surged 14% Today
2021-10-26 18:39The stock will be part of a well-known index.
Dear SRNG Stock Fans, Mark Your Calendars for Ginkgo Bioworks' Debut on Sept. 17
2021-09-15 13:39Soaring Eagle Acquisition is about to complete its merger with Ginkgo Bioworks, and SRNG stock is reacting well. Here's why.
Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
2021-09-14 11:27Avid Bioservices (CDMO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q2 2021 Results - Earnings Call Transcript
2021-09-08 21:44Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q2 2021 Results - Earnings Call Transcript
Avid Bioservices: FDA CGMP Stringency Provides Stable Long Outlook
2021-08-11 15:09Healthcare is one market no one can say is going to slow down, and so, many of the best investments lie within.
Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D.
2021-07-01 08:05Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry Experience Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry Experience
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q4 2021 Results - Earnings Call Transcript
2021-06-29 23:11Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q4 2021 Results - Earnings Call Transcript
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
2021-06-29 16:05-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- -- Achieved Four Consecutive Quarters of Operational Profitability During Fiscal 2021 --